Auricular Vagal Neuromodulation and its Application in Patients with Heart Failure and Reduced Ejection Fraction.

Sérgio Lívio Menezes Couceiro Lucas Bonacossa Sant'Anna Mariana Bonacossa Sant'Anna Renata S Matos Menezes Evandro Tinoco Mesquita Fernando Mendes Sant'Anna

Published in: Arquivos brasileiros de cardiologia (2023)

taVNS is a safe to perform and easy intervention and suggests a probable benefit in HF by improving heart rate variability, which indicates better autonomic balance. New studies with more patients are needed to answer the questions raised by this study.

Keyphrases

heart rate variability
heart rate
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
randomized controlled trial
peritoneal dialysis
blood pressure
heart failure
atrial fibrillation
patient reported outcomes